Comparison of multiple steroid concentrations in serum and dried blood spots throughout the day of patients with congenital adrenal hyperplasia

Kyriakie Sarafoglou, John H. Himes, Jean M. Lacey, Brian C. Netzel, Ravinder Jit Singh, Dietrich Matern

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Background/Aim: Periodic measurement of plasma concentrations of cortisol precursors on a clinic visit may be of limited value in patients with congenital adrenal hyperplasia because it does not reflect a patient's circadian patterns of adrenal steroid secretion. Steroid profiling in dried blood spots (DBS) may allow for more frequent and sensitive monitoring. Methods: We compared the agreement between 17α-hydroxyprogesterone (17-OHP) and androstenedione (D4A) levels determined from DBS samples and concurrently collected serum samples. Blood was drawn from 9 congenital adrenal hyperplasia patients every 4 h over a 24-hour period. Serum and DBS steroid levels were measured by liquid chromatography tandem mass spectrometry. Results: DBS determinations of 17-OHP overestimated corresponding serum levels (mean difference 1.67 ng/ml), and underestimated D4A serum levels (mean difference 0.84 ng/ml). However, the DBS assay yielded excellent agreement (97%) with serum 17-OHP, but did considerably poorer for D4A (31%). Conclusions: Our results indicate an excellent agreement between DBS and serum 17-OHP measurements to identify the peaks and troughs associated with an individual's circadian pattern. Larger-scale studies are required to evaluate the utility of DBS for home monitoring and to determine if more frequent monitoring leads to improved clinical outcomes.

Original languageEnglish (US)
Pages (from-to)19-25
Number of pages7
JournalHormone Research in Paediatrics
Volume75
Issue number1
DOIs
StatePublished - Jan 2011

Fingerprint

Congenital Adrenal Hyperplasia
Steroids
Serum
17-alpha-Hydroxyprogesterone
Androstenedione
Ambulatory Care
Tandem Mass Spectrometry
Liquid Chromatography
Hydrocortisone

Keywords

  • 17α-hydroxyprogesterone
  • Circadian rhythms of hormones
  • Congenital adrenal hyperplasia
  • Glucocorticoid therapy
  • Tandem mass spectrometry

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Pediatrics, Perinatology, and Child Health

Cite this

Comparison of multiple steroid concentrations in serum and dried blood spots throughout the day of patients with congenital adrenal hyperplasia. / Sarafoglou, Kyriakie; Himes, John H.; Lacey, Jean M.; Netzel, Brian C.; Singh, Ravinder Jit; Matern, Dietrich.

In: Hormone Research in Paediatrics, Vol. 75, No. 1, 01.2011, p. 19-25.

Research output: Contribution to journalArticle

Sarafoglou, Kyriakie ; Himes, John H. ; Lacey, Jean M. ; Netzel, Brian C. ; Singh, Ravinder Jit ; Matern, Dietrich. / Comparison of multiple steroid concentrations in serum and dried blood spots throughout the day of patients with congenital adrenal hyperplasia. In: Hormone Research in Paediatrics. 2011 ; Vol. 75, No. 1. pp. 19-25.
@article{70f4583b6d8444f9abd40fba24b401e1,
title = "Comparison of multiple steroid concentrations in serum and dried blood spots throughout the day of patients with congenital adrenal hyperplasia",
abstract = "Background/Aim: Periodic measurement of plasma concentrations of cortisol precursors on a clinic visit may be of limited value in patients with congenital adrenal hyperplasia because it does not reflect a patient's circadian patterns of adrenal steroid secretion. Steroid profiling in dried blood spots (DBS) may allow for more frequent and sensitive monitoring. Methods: We compared the agreement between 17α-hydroxyprogesterone (17-OHP) and androstenedione (D4A) levels determined from DBS samples and concurrently collected serum samples. Blood was drawn from 9 congenital adrenal hyperplasia patients every 4 h over a 24-hour period. Serum and DBS steroid levels were measured by liquid chromatography tandem mass spectrometry. Results: DBS determinations of 17-OHP overestimated corresponding serum levels (mean difference 1.67 ng/ml), and underestimated D4A serum levels (mean difference 0.84 ng/ml). However, the DBS assay yielded excellent agreement (97{\%}) with serum 17-OHP, but did considerably poorer for D4A (31{\%}). Conclusions: Our results indicate an excellent agreement between DBS and serum 17-OHP measurements to identify the peaks and troughs associated with an individual's circadian pattern. Larger-scale studies are required to evaluate the utility of DBS for home monitoring and to determine if more frequent monitoring leads to improved clinical outcomes.",
keywords = "17α-hydroxyprogesterone, Circadian rhythms of hormones, Congenital adrenal hyperplasia, Glucocorticoid therapy, Tandem mass spectrometry",
author = "Kyriakie Sarafoglou and Himes, {John H.} and Lacey, {Jean M.} and Netzel, {Brian C.} and Singh, {Ravinder Jit} and Dietrich Matern",
year = "2011",
month = "1",
doi = "10.1159/000315910",
language = "English (US)",
volume = "75",
pages = "19--25",
journal = "Hormone Research in Paediatrics",
issn = "1663-2818",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Comparison of multiple steroid concentrations in serum and dried blood spots throughout the day of patients with congenital adrenal hyperplasia

AU - Sarafoglou, Kyriakie

AU - Himes, John H.

AU - Lacey, Jean M.

AU - Netzel, Brian C.

AU - Singh, Ravinder Jit

AU - Matern, Dietrich

PY - 2011/1

Y1 - 2011/1

N2 - Background/Aim: Periodic measurement of plasma concentrations of cortisol precursors on a clinic visit may be of limited value in patients with congenital adrenal hyperplasia because it does not reflect a patient's circadian patterns of adrenal steroid secretion. Steroid profiling in dried blood spots (DBS) may allow for more frequent and sensitive monitoring. Methods: We compared the agreement between 17α-hydroxyprogesterone (17-OHP) and androstenedione (D4A) levels determined from DBS samples and concurrently collected serum samples. Blood was drawn from 9 congenital adrenal hyperplasia patients every 4 h over a 24-hour period. Serum and DBS steroid levels were measured by liquid chromatography tandem mass spectrometry. Results: DBS determinations of 17-OHP overestimated corresponding serum levels (mean difference 1.67 ng/ml), and underestimated D4A serum levels (mean difference 0.84 ng/ml). However, the DBS assay yielded excellent agreement (97%) with serum 17-OHP, but did considerably poorer for D4A (31%). Conclusions: Our results indicate an excellent agreement between DBS and serum 17-OHP measurements to identify the peaks and troughs associated with an individual's circadian pattern. Larger-scale studies are required to evaluate the utility of DBS for home monitoring and to determine if more frequent monitoring leads to improved clinical outcomes.

AB - Background/Aim: Periodic measurement of plasma concentrations of cortisol precursors on a clinic visit may be of limited value in patients with congenital adrenal hyperplasia because it does not reflect a patient's circadian patterns of adrenal steroid secretion. Steroid profiling in dried blood spots (DBS) may allow for more frequent and sensitive monitoring. Methods: We compared the agreement between 17α-hydroxyprogesterone (17-OHP) and androstenedione (D4A) levels determined from DBS samples and concurrently collected serum samples. Blood was drawn from 9 congenital adrenal hyperplasia patients every 4 h over a 24-hour period. Serum and DBS steroid levels were measured by liquid chromatography tandem mass spectrometry. Results: DBS determinations of 17-OHP overestimated corresponding serum levels (mean difference 1.67 ng/ml), and underestimated D4A serum levels (mean difference 0.84 ng/ml). However, the DBS assay yielded excellent agreement (97%) with serum 17-OHP, but did considerably poorer for D4A (31%). Conclusions: Our results indicate an excellent agreement between DBS and serum 17-OHP measurements to identify the peaks and troughs associated with an individual's circadian pattern. Larger-scale studies are required to evaluate the utility of DBS for home monitoring and to determine if more frequent monitoring leads to improved clinical outcomes.

KW - 17α-hydroxyprogesterone

KW - Circadian rhythms of hormones

KW - Congenital adrenal hyperplasia

KW - Glucocorticoid therapy

KW - Tandem mass spectrometry

UR - http://www.scopus.com/inward/record.url?scp=79151477227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79151477227&partnerID=8YFLogxK

U2 - 10.1159/000315910

DO - 10.1159/000315910

M3 - Article

VL - 75

SP - 19

EP - 25

JO - Hormone Research in Paediatrics

JF - Hormone Research in Paediatrics

SN - 1663-2818

IS - 1

ER -